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1. Introduction 
Aluminum phosphide (AlP) is used throughout the world as pesticides to protect stored 
grains from rodents and other pests (Cienki, 2001).  The chemical is usually formulated in 
pellets, granules or as a dust. Upon contact with moisture in the environment, AlP 
undergoes a chemical reaction yielding phosphine gas (PH3), which is the active pesticidal 
component and a very toxic system poison, makes acute AlP poisoning (AAlPP) extremely 
dangerous (Sasser et al., 1998). 
AAlPP has been reported in literature since 1985. The majority of cases of AlP poisoning 
involving intentional suicide acts. It is a major health problem with a high mortality rate 
especially in developing countries where AlP is low cost and easily accessible (Mehpour et 
al., 2008; Louriz et al., 2009). Patients who intend to commit suicide take tablets. Once mixed 
with hydrochloric acid in the stomach, PH3 is immediately released and absorbed rapidly 
via the lungs causing systemic poisoning (Proudfoot, 2009). However, accidental exposure 
to AlP is a relatively common cause of poisoning from agriculture chemical exposure in 
many countries. The manufacture and application of AlP fumigants pose risks of inhalation 
exposure to PH3 (Sudakin, 2005).  
During the past 35 years, high mortality rates have been reported following significant 
exposures to aluminum phosphide. This mortality rates vary from 40% to 80% (Chugh et al., 
1991).  
2. Toxicology of phosphine gas 
The toxicity of AlP is attributed to the liberation of PH3 gas which is cytotoxic and causes 
free radical mediated injury (Sudakin, 2005). 
PH3 a nucleophile, acts as a strong reducing agent capable of inhibiting cellular enzymes 
involved in several metabolic processes. Early studies on PH3 demonstrated specific 
inhibitory effects on mitochondrial cytochrome c oxidase. Experimental and observational 
studies have subsequently demonstrated that the inhibition of cytochrome c oxidase and 
other enzymes leads to the generation superoxide radicals and cellular peroxides. Cellular 
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Fig. 1. Aluminum phosphide and liberation of phosphine gas. Al≡P : aluminum phosphide ; 
PH3 :  phosphine gas 
injury subsequently occurs through lipid peroxidation and other oxidant mechanisms 
(Chugh et al., 1996). Indeed, significant decreases in glutathione concentrations were shown 
in different tissues during AlP  poisoning (Hsu et al., 2002). Glutathione is known to be an 
important factor protecting against oxidation by catalyzing the reduction of the oxygen 
peroxide in O2 and H2O. 
Mutagenic effects resulting from oxidative damage to DNA have been reported in vitro. A 
cytogenetic study of phosphide fumigant applicators reported a significantly higher 
incidence of chromatid gaps and deletions in comparison to controls (Hsu et al., 1998).  
Very little information is available relating to the toxicokinetics of PH3 in humans. In an 
investigation of a series of patients with acute AlP poisoning , indicators of oxidative stress 
(malonydialdehyde levels, superoxide dismutase and catalase activity) appeared to peak 
within 48 hours of exposure, with normalization of most indicators occurring by day 5 
(Chugh et al., 1996a). Chugh et al. reported that, serum PH3 levels correlate positively with 
the severity of poisoning and levels equal to or less than 1.067 ± 0.16 mg % appear to be the 
limit of PH3 toxicity (Chugh et al., 1996b).  
A bedside test has been described for the diagnosis of AlP ingestion, using gastric aspirates 
and paper strips impregnated with silver nitrate. The test was found to be positive in 100% 
of cases of AlP ingestion (Chugh et al., 1994). The same test was also investigated to detect 
PH3 gas in the exhaled air of patients with intoxication with AlP ingestion, and the results 
were positive in 50 % of cases. 
3. Acute aluminum phosphide poisoning  
3.1 Clinical features of AAlPP 
AAlPP results in the rapid onset of gastrointestinal signs and symptoms, including 
epigastric pain and recurrent, profuse vomiting. Characteristic garlic smell of PH3 in the 
patient’s expired breath. Cardiovascular manifestations include hypotention and profound 
circulatory collapse.  Neurological manifestations following acute poisoning include 
headache, anxiety and dizziness, frequently accompanied by a normal mental state 
(National Institute of occupational Safety and Health  [NIOSH], 2003). Pulmonary injury 
and oedema have been described. Acute renal and liver injury can also develop. The 
prognosis from suicidal ingestion of AlP is poor.  
The major lethal consequence of AAlPP, myocardial  suppression with profound circulatory 
collapse, is reportedly secondary to toxins generated, which lead to direct effects on cardiac 
myocytes, fluid loss induced by several episodes of vomiting and adrenal gland damage.  
The AAlPP is involving young patients without history of cardiac diseases. However, 
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clinical, biological, electrical and histological observations suggest that myocardial 
involvement is responsible for the acute circulatory insufficiency (Lall et al., 1997). 
3.2 Biological abnormalities in AAlPP 
Increased CK with raised cardiac marker CK-MB fraction has been previously reported 
point to severe myocardial damage (Nakakita et al., 2009).  Controversies exist about the 
magnesium level and prognosis of AAlPP. Some studies seem to suggest that there is 
hypomagnesaemia associated with AAlPP and that there is a direct relationship between 
abnormal electrocardiographic findings and low magnesium levels. They report reduced 
mortality rates with magnesium therapy in these patients (Chugh et al., 1991).  However 
other studies have shown no such benefits and some have even demonstrated 
hypermagnesaemia in patients with AAlPP (Singh et al., 1991). The pathogenesis of 
magnesium level abnormalities was not clear. 
3.3 Histological injury in AAlPP 
PH3 also has corrosive effects on tissues. Louriz et al investigated microscopic changes in vital 
organs of the body, liver, heart and kidneys (Louriz et al., 2009). These changes were found to 
be suggestive of cellular hypoxia. Other recent studies with more patients were performed and 
showed congestion, edema and leukocytie or leukocyte infiltration in the liver, kidneys, heart, 
stomach, lungs, brain and adrenals (Arora et al., 1995; Sinha et al., 2005).  
Nakakita studied the histology of the heart. Histopathological finding of myocyte 
vacuolation and myocytolysis and degeneration are both suggestive of myocardial injury. 
The areas of increased waviness of myocardial fibers indicate an episode of myocardial 
infarction (Nakakita et al., 2009). 
3.4 Cardiotoxicity of AlP 
The toxicity of AlP is systemic and can affect all organs, but particularly cardiac and 
vascular tissues.  Myocardial injury following AlP poisoning has been documented on 
electrocardiograms in several studies. AlP induced cardiotoxicity was responsible for a high 
level of mortality. Cardiac toxicity due to AlP and PH3 exposure is represented by a 
depression in myocardial cellular metabolism, as well as myocardial necrosis due to the 
release of reactive oxygen intermediates.  
Several studies noted electric abnormalities in 38% to 91% of cases (Chugh et al., 1991; Karla 
et al., 1991). There are conduction disorders such as right and left  bundle branch block 
(25%), atrioventricular block (8%) and rarely, sinoatrial block (Karla et al., 1991). On the 
other hand, cardiac dysrhythmias were described as atrial fibrillation (4% to 61%), junctional 
rhythm (4% to 100%), ventricular and atrial extrasyxtoles (18%) and ventricular fibrillation 
(2%) (Gupta et al., 1995; Louriz et al, 2009). Finally, re-polarization disorders were also 
reported, such as ST segment depression (12% to 65%), ST segment elevation (4% to 65%) 
and T wave inversion (36%) induced by AAlPP (Lall et al., 1997).  
Indeed, in Shadnia’s study, 39 patients admitted to the ICU with AAlPP were studied. 
Average time elapsed between poisoning  and admission at the hospital was 3.4 ± 3.5 hours. 
Average ingested amount was 1.4 ± 0.9 tablets. ECG abnormalities were found in 17 (43.6%) 
cases at the time of admission with ST-T changes in 8 cases. Ischemic change in 3 cases and 
dysrhythmias in 6 cases. The nature of these dysrhythmias was not described. The mortality 
rate was high, about 67%. In this study, ECG abnormalities were a prognostic factor 
(Shadnia et al., 2010).  
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Fig. 2. Electrocardiographic changes following aluminium phosphide poisoning. 12-leads 
surface ECG recorded on admission showing: (A) Sinusal bradycardia (B) Ventricular 
extrasystoles (C) Sinusal tachycardia with ST segment depression in the leads D1, aVL, V5 
and V6 (D1, D2 &D3) Sinusal tachycardia with ST-T changes.  
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In Louriz’s study, 49 patients were enrolled. The ingested dose was 1.2 ± 0.7 grams. The time 
between ingestion and admission to the medical ICU was 9.1 ± 10.7 hours. The ECG was 
abnormal in 28 cases (58.7%) at the time of admission with myocardial ischemia in 21 cases, 
atrial fibrillation in 6 cases, ventricular extrasystoles in 9 cases and ventricular fibrillation in 
one case.  The mortality rate was 49%. In this study, ECG abnormalities were also a 
prognostic factor (Louriz et al., 2009).  
In Mathai’s study, 27 patients with AAlPP were admitted into the ICU. One and half grams 
of poison was consumed. There was a mean delay of 2.1 ± 1.55 hours before presenting to 
the hospital. Thirteen (48.1%) patients had dysrhythmia at admission of which the majority 
(69%) of supraventricular origin. Ventricular arythmias was found in 4 cases. The mortality 
rate was 59.3%.  In this study, the presence of ECG abnormalities did not predict mortality 
(Mathai et al., 2010).  
In these 3 studies cited above, there wasn’t any association between the dose of poison 
consumed or the time delay in presentation to the hospital with the mortality. All the ECG 
abnormalities found in these studies were recorded at the admission to the hospital. 
However, other ECG changes could be found during the hospitalization.  
Indeed, Bogle et al described a case of a lethal AAlPP caused by deliberate ingestion of AlP. 
ECG showed a sinus tachycardia 2 hours after ingestion of a 10 g sachet of pesticide with 
56% of AlP. ECG recorded 12 hours after ingestion showed extreme widening of the QRS 
complexe despite amiodarone therapy.  The rate of ECG abnormalities resulting of AAlPP 
might be under estimated (Bogle et al., 2006).  
Some electrical abnormalities noted in our practice are reported in Figure 2. 
In several studies, echocardiography showed a global hypokinesis of the left ventrivule 






A)                                                                   B) 
Fig. 3. Echocardiographically parasternal long axis depicted improvement of ventricle 
function following aluminum phosphide poisoning . A) Echocardiogram obtained on the 
second day after admission depicts global hypokinesis with LVEF of 30% and dilatation of 
LV. B) Echocardiogram taken eight days after admission showed improvement of ventricle 
function.  
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Indeed, Bahsin et al showed a generalized hypokinesis of left ventricle wall and 
interventricular septum in 80% of their cases. This study revealed akinesis and pericarditis in 
3% and 35% of the cases, respectively (Bhasin et al., 1991). Thus, Bajaj et al showed a global 
hypokinesis of the left ventricle in the three patients that underwent serial ventriculography 
(Bajaj et al., 1988). However, other authors have described a focal myocardial necrosis 
(Singh et al., 1991; Wilson et al., 1980). At a patient hospitalized in our intensive care unit, 
we observed an unusual and important dilation of right cardiac cavities explained partially 
by hypokinesia of the left ventricle but probably also by the direct toxicity of the AlP on the 
right ventricle (Figure 4). 
 
 
Fig. 4. Echocardiography parasternal long axis depicted improvement of ventricule function. 
Echocardiogram obtained at admission depicts global hypokinesis with left ventricle 
ejection fraction (LVEF) of 40% and important dilation of right ventricle and auricle.  
4. Conclusion  
The severity of the poisoning is judged by the cardiac failure and the unavailability of an 
antidote. Myocardial injury following AAlPP is responsible for significant mortality. Despite 
all intensive medical care efforts in supportive therapy, the prognosis of AAlPP is poor. 
Therefore the use and availability of the pesticide aluminium phosphide should be 
restricted as much as possible. 
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